INTERNATIONAL PATENT: SYNACT PHARMA APS FILES APPLICATION FOR "TREATMENT OF SUBPOPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS"

GENEVA, June 23 -- SYNACT PHARMA APS (Dronninggards Alle 1362840 Holte) filed a patent application (PCT/EP2024/075319) for "TREATMENT OF SUBPOPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS" on Sep 11, 2024. With publication no. WO/2025/124760, the details related to the patent application was published on Jun 19, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOESEN, Thomas (Lipkesgade 25, 2.tv.2100 Copenhagen O), JONASSEN, Thomas Engelbrecht Nordkild (Pile Alle 202840 Holte)

Abstract: Provided is a therapy comprising a compound of formula (I), such as AP1189, and methotrexate for the tr...